Baxter Hyland Immuno; est. no. 0140

Description

550 North Brand Boulevard, Glendale, CA 91203; with facilities in Lessines, Belgium; (3) A-1220 Vienna, Austria; A-2304 Orth/Donau, Austria; Beaufort, SC; Cleveland, MS; Los Angeles, CA; Rochester, MI; Round Lake, IL; Thousand Oaks, CA; Lessines Belgium; Vienna Austria; Orth/Donau Austria; Beaufort, SC; Cleveland, MS; Hoover, AL; Los Angeles, CA; Rochester, MI; Round Lake, IL; and Thousand Oaks, CA; A subsidiary of Baxter Healthcare Corp; In 1952, Baxter acquired Hyland Labs., the first U.S. company to commercially manufacture human plasma; Baxter acquired Immuno Intl., now Baxter AG, and its products have now been folded into this establishement license (no. 0140); Baxter completed acquisition of North American Vaccine, Inc. in mid-2000; In April 2005, Baxter acquired the plasma and plasma derivatives business of the American National Red Cross.

Related product monographs:

Location

Glendale CA 91203 USA

Reference Number

140